Electronic Alerts for Oxygen Levels During Mechanical Ventilation
(TOOLs Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to improve oxygen level management for patients on mechanical ventilation in intensive care. By using electronic alerts, the researchers aim to maintain optimal oxygen levels, avoiding both insufficient and excessive oxygen, which can be harmful. The trial will compare two methods: using electronic alerts for oxygen adjustment and following standard guidelines with one-time doctor orders. It targets individuals who are critically ill and require ventilation for more than a day.
As an unphased trial, it provides a unique opportunity to contribute to important research that could enhance patient care in critical settings.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this oxygen titration protocol with electronic alerts is safe?
Research has shown that using electronic alerts to manage oxygen levels during mechanical ventilation is generally safe. Studies have found that these alerts can adjust oxygen levels without causing harm. While specific data on negative effects from these studies is lacking, using electronic health records for oxygen adjustments appears well-tolerated. This suggests the process is unlikely to cause significant side effects in patients. Maintaining balanced oxygen levels is crucial, as both too little and too much oxygen can be harmful. This method aims to help maintain that balance safely.12345
Why are researchers excited about this trial?
Researchers are excited about this trial because it explores a novel method for managing oxygen levels during mechanical ventilation using electronic alerts. Unlike the standard practice where oxygen titration is done based on one-time physician orders, this method employs real-time alerts and a decision support tool for respiratory therapists, potentially allowing for more precise and timely adjustments. This approach could lead to improved patient outcomes by ensuring oxygen levels are kept within optimal ranges more consistently.
What evidence suggests that electronic alerts for oxygen titration during mechanical ventilation are effective?
Research has shown that electronic alerts can effectively manage oxygen levels in patients on breathing machines. In this trial, participants in the intervention arm will receive oxygen titration based on these alerts, which have been proven to reduce both low oxygen levels (hypoxia) and high oxygen levels (hyperoxia). One study found that patients using this system had their oxygen therapy adjusted earlier, with 14.1% being taken off oxygen sooner compared to just 4.3% without it. This suggests that electronic alerts can manage oxygen more accurately, leading to better patient outcomes.12346
Who Is on the Research Team?
Sonal R Pannu, M.D.
Principal Investigator
Ohio State University
Are You a Good Fit for This Trial?
This trial is for critically ill patients needing mechanical ventilation for at least a day. It's not suitable for those without research authorization, with conditions like pneumothorax, carbon monoxide poisoning, recent severe heart attacks or those undergoing hyperbaric oxygen therapy or who are pregnant.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Oxygen titration using electronic alerts and decision support tool in the intervention arm, and standard care in the control arm
Follow-up
Participants are monitored for ventilator-free days and ICU length of stay
Hospital Stay
Monitoring of duration of stay in the hospital after patient enrollment
What Are the Treatments Tested in This Trial?
Interventions
- Electronic Alerts
- Titration of Oxygen Levels During Mechanical Ventilation With Electronic Alerts
Find a Clinic Near You
Who Is Running the Clinical Trial?
Ohio State University
Lead Sponsor
National Center for Advancing Translational Sciences (NCATS)
Collaborator